Cargando…
Prognostic and predictive value of a five-molecule panel in resected pancreatic ductal adenocarcinoma: A multicentre study
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) has a devastating prognosis. The performance of clinicopathologic parameters and molecules as prognostic factors remains limited and inconsistent. The present study aimed to construct a multi-molecule biomarker panel to more accurately predict post...
Autores principales: | Guo, Jun-Chao, Zhang, Peng, Zhou, Li, You, Lei, Liu, Qiao-Fei, Zhang, Zhi-Gang, Sun, Bei, Liang, Zhi-Yong, Lu, Jun, Yuan, Da, Tan, Ai-Di, Sun, Jian, Liao, Quan, Dai, Meng-Hua, Xiao, Gary Guishan, Li, Shao, Zhang, Tai-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195527/ https://www.ncbi.nlm.nih.gov/pubmed/32361251 http://dx.doi.org/10.1016/j.ebiom.2020.102767 |
Ejemplares similares
-
Plasminogen Activator Inhibitor 1 as a Poor Prognostic Indicator in Resectable Pancreatic Ductal Adenocarcinoma
por: Liu, Wen-Jing, et al.
Publicado: (2018) -
Cbl-b predicts postoperative survival in patients with resectable pancreatic ductal adenocarcinoma
por: Dong, Qian, et al.
Publicado: (2017) -
Biomarker Panel for the Diagnosis of Pancreatic Ductal Adenocarcinoma
por: Kim, Hongbeom, et al.
Publicado: (2020) -
Preoperative Serum CA125 Levels Predict the Prognosis in Hyperbilirubinemia Patients With Resectable Pancreatic Ductal Adenocarcinoma
por: Chen, Tao, et al.
Publicado: (2015) -
WT1-associated protein is a novel prognostic factor in pancreatic ductal adenocarcinoma
por: Li, Bing-Qi, et al.
Publicado: (2017)